<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Treatment of acute calculous cholecystitis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Treatment of acute calculous cholecystitis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Treatment of acute calculous cholecystitis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Charles M Vollmer, Jr, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Salam F Zakko, MD, FACP, AGAF</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nezam H Afdhal, MD, FRCPI</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stanley W Ashley, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 02, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Acute cholecystitis is a syndrome of right upper quadrant pain, fever, and leukocytosis associated with gallbladder inflammation. It typically occurs in patients with gallstones (ie, acute calculous cholecystitis [ACC]), while acalculous cholecystitis accounts for a minority (5 to 10 percent) of cases. Complications of acute cholecystitis include gallbladder gangrene or perforation, which can be life-threatening. </p><p>Patients with ACC usually present with severe and steady abdominal pain in the right upper quadrant or epigastrium, fever, and leukocytosis. A positive Murphy's sign on physical examination supports the diagnosis. In most cases, the diagnosis can be established with an abdominal ultrasound or a cholescintigraphy if the ultrasound is equivocal. (See  <a class="medical medical_review" href="/d/html/666.html" rel="external">"Acute calculous cholecystitis: Clinical features and diagnosis"</a>.)</p><p>Cholecystectomy is the mainstay of treatment for ACC. Poor surgical candidates may benefit from initial nonoperative management with antibiotics and a gallbladder drainage procedure; those whose surgical risk improves after resolution of the acute inflammation should undergo elective gallbladder surgery to prevent recurrent symptoms.</p><p>The treatment of ACC will be reviewed here. Other topics on gallstone diseases and their treatment include:</p><p class="bulletIndent1"><span class="glyph">●</span>The approach to patients with asymptomatic gallstones. (See  <a class="medical medical_review" href="/d/html/654.html" rel="external">"Overview of gallstone disease in adults"</a> and  <a class="medical medical_review" href="/d/html/673.html" rel="external">"Approach to the management of gallstones"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The approach to the pregnant patient with gallstones. (See  <a class="medical medical_review" href="/d/html/15095.html" rel="external">"Gallstone diseases in pregnancy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The clinical manifestations and diagnosis of cholecystitis. (See  <a class="medical medical_review" href="/d/html/666.html" rel="external">"Acute calculous cholecystitis: Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis and management of acalculous cholecystitis. (See  <a class="medical medical_review" href="/d/html/672.html" rel="external">"Acalculous cholecystitis: Clinical manifestations, diagnosis, and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Xanthogranulomatous cholecystitis. (See  <a class="medical medical_review" href="/d/html/635.html" rel="external">"Xanthogranulomatous cholecystitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Techniques of cholecystectomy. (See  <a class="medical medical_review" href="/d/html/3685.html" rel="external">"Laparoscopic cholecystectomy"</a> and  <a class="medical medical_review" href="/d/html/15096.html" rel="external">"Open cholecystectomy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The approach to choledocholithiasis. (See  <a class="medical medical_review" href="/d/html/13922.html" rel="external">"Choledocholithiasis: Clinical manifestations, diagnosis, and management"</a> and  <a class="medical medical_review" href="/d/html/15093.html" rel="external">"Surgical common bile duct exploration"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">SUPPORTIVE CARE</span><span class="headingEndMark"> — </span>Patients diagnosed with acute calculous cholecystitis (ACC) should be admitted to the hospital and provided with supportive care including [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Intravenous hydration.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Correction of any electrolyte abnormalities.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pain control.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intravenous antibiotics.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients should be kept fasting, and although uncommonly needed, those who are vomiting should have placement of a nasogastric tube. (See  <a class="medical medical_review" href="/d/html/15070.html" rel="external">"Inpatient placement and management of nasogastric and nasoenteric tubes in adults"</a>.)</p><p></p><p class="headingAnchor" id="H11016944"><span class="h2">Pain control</span><span class="headingEndMark"> — </span>Pain control in patients with ACC can usually be achieved with nonsteroidal anti-inflammatory drugs (NSAIDs) or opioids. </p><p>We prefer <a class="drug drug_general" data-topicid="8591" href="/d/drug information/8591.html" rel="external">ketorolac</a> for patients with biliary colic. Treatment usually relieves symptoms within 20 to 30 minutes. Opioids, such as <a class="drug drug_general" data-topicid="9788" href="/d/drug information/9788.html" rel="external">morphine</a>, <a class="drug drug_general" data-topicid="8538" href="/d/drug information/8538.html" rel="external">hydromorphone</a>, or <a class="drug drug_general" data-topicid="9608" href="/d/drug information/9608.html" rel="external">meperidine</a>, are appropriate therapy for patients who have contraindications to NSAIDs or who do not achieve adequate pain relief with an NSAID, which may be more common in patients with acute cholecystitis compared with those with uncomplicated biliary colic.</p><p>Although <a class="drug drug_general" data-topicid="9608" href="/d/drug information/9608.html" rel="external">meperidine</a> was traditionally the opioid of choice in patients with gallstone disease because it was thought to have less of an effect on sphincter of Oddi motility than <a class="drug drug_general" data-topicid="9788" href="/d/drug information/9788.html" rel="external">morphine</a> [<a href="#rid2">2-4</a>], a systematic review found that all opioids increase sphincter of Oddi pressure [<a href="#rid3">3</a>]. Thus, there are insufficient data to avoid morphine, especially considering that morphine requires less frequent dosing than meperidine.</p><p class="headingAnchor" id="H3"><span class="h2">Antibiotics</span><span class="headingEndMark"> — </span>For patients with complicated ACC, broad-spectrum antibiotics are required. For those with uncomplicated ACC, we also suggest administering antibiotics. Once started, antibiotic therapy should continue until either the gallbladder is removed or the cholecystitis clinically resolves. </p><p>ACC is primarily an inflammatory process, but secondary infection of the gallbladder can occur as a result of cystic duct obstruction and bile stasis [<a href="#rid5">5,6</a>]. The rate of gallbladder empyema and pericholecystic abscess is overall low, but patients can easily develop life-threatening gram-negative sepsis from uncomplicated, acute cholecystitis. Thus, antibiotics are commonly administered prophylactically to protect against sepsis and wound infection [<a href="#rid7">7</a>]. However, since data are conflicted as to whether antibiotics are required for the treatment of uncomplicated acute cholecystitis [<a href="#rid5">5,6,8-10</a>], some clinicians do not use antibiotics in very mild cases. </p><p>In the PEANUT II trial, 457 patients with mild-to-moderate ACC (immediate cholecystectomy indicated) received <a class="drug drug_general" data-topicid="9214" href="/d/drug information/9214.html" rel="external">cefazolin</a> before incision or no antibiotic prophylaxis [<a href="#rid11">11</a>]. The number of surgical site infections was significantly higher in the no-prophylaxis group (5.3 versus 12.1 percent; P = 0.010). Other complications or length of stay were not different.</p><p>Regardless, it is generally agreed that antibiotics are indicated for all complicated ACC (ie, gallbladder gangrene/necrosis, rupture, or emphysematous cholecystitis) and for uncomplicated ACC in patients who are frail, have diabetes, or are immunocompromised [<a href="#rid8">8,12</a>]. </p><p>When empiric antibiotic therapy is indicated, the chosen agent(s) should cover the most common pathogens of the <em>Enterobacteriaceae</em> family, including gram-negative rods and anaerobes [<a href="#rid6">6</a>]. In a study of 467 patients, including a control group of 42 with normal biliary trees, positive bile cultures were found in 22 percent of patients with symptomatic gallstones and 46 percent of patients with acute cholecystitis [<a href="#rid13">13</a>]. The most frequent isolates from the gallbladder or common bile duct were <em>Escherichia coli</em> (41 percent), <em>Enterococcus</em> (12 percent), <em>Klebsiella</em> (11 percent), and <em>Enterobacter</em> (9 percent). Whenever possible, the chosen agent(s) should also achieve adequate concentrations in bile. </p><p>We recommend the following antibiotic regimens for acute cholecystitis based on the patient's individual risk category [<a href="#rid8">8</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>For patients with community-acquired acute cholecystitis of low risk  (<a class="graphic graphic_table graphicRef106948" href="/d/graphic/106948.html" rel="external">table 1</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with community-acquired acute cholecystitis of high risk  (<a class="graphic graphic_table graphicRef106949" href="/d/graphic/106949.html" rel="external">table 2</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with health-care-associated acute cholecystitis  (<a class="graphic graphic_table graphicRef106950" href="/d/graphic/106950.html" rel="external">table 3</a>)</p><p></p><p>The Tokyo Guidelines 2018, an international reference commonly cited for the treatment of acute cholangitis and acute cholecystitis, agreed with the recommendations above in general but included additional agents in each patient category (eg, <a class="drug drug_general" data-topicid="8675" href="/d/drug information/8675.html" rel="external">ertapenem</a>)  (<a class="graphic graphic_table graphicRef117719" href="/d/graphic/117719.html" rel="external">table 4</a>) [<a href="#rid14">14</a>]. </p><p>The choosing of an antibiotic regimen within each patient category is governed by local practices, taking into consideration the antibiogram and formulary of each institution. The chosen agents should subsequently be tailored to culture and susceptibility results when they become available [<a href="#rid5">5</a>]. </p><p>The duration of antibiotic therapy is generally tailored to the clinical situation. For patients undergoing cholecystectomy for uncomplicated cholecystitis, we discontinue antibiotics the day after the cholecystectomy. Our practice is supported by results from several randomized trials:</p><p class="bulletIndent1"><span class="glyph">●</span>A multicenter trial randomly assigned 414 patients hospitalized for mild or moderate calculous cholecystitis to continue their preoperative antibiotic regimen for five days (2 g <a class="drug drug_general" data-topicid="8676" href="/d/drug information/8676.html" rel="external">amoxicillin-clavulanate</a>, three times daily) or to receive no antibiotics following cholecystectomy [<a href="#rid15">15</a>]. No significant differences in postoperative infection rates (17 versus 15 percent) were found. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A single-center trial randomly assigned 195 patients who underwent laparoscopic cholecystectomy for mild-to-moderate calculous cholecystitis to receive either <a class="drug drug_general" data-topicid="8676" href="/d/drug information/8676.html" rel="external">amoxicillin-clavulanate</a> or placebo for five days [<a href="#rid16">16</a>]. Similar numbers of patients developed postoperative infectious complications (5.8 percent placebo versus 6.6 percent antibiotics), and there were no differences in other outcomes (eg, hospital stay, readmission, and reoperation). </p><p></p><p>Clinical judgment should dictate antibiotic management in more complicated scenarios, such as in the septic postoperative patient. The duration of antibiotic therapy for high-risk patients managed nonoperatively is discussed separately. (See <a class="local">'Antibiotic therapy'</a> below.)</p><p>Antibiotic therapy for intra-abdominal infections, including acute cholecystitis, is also discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/101694.html" rel="external">"Antimicrobial approach to intra-abdominal infections in adults"</a>.)</p><p class="headingAnchor" id="H3556800859"><span class="h1">INDICATIONS FOR EMERGENCY CHOLECYSTECTOMY</span><span class="headingEndMark"> — </span>Despite supportive care, emergency cholecystectomy is indicated in a minority of patients in the presence of: </p><p class="headingAnchor" id="H4137122614"><span class="h2">Complicated acute cholecystitis</span><span class="headingEndMark"> — </span>Complicated acute cholecystitis, including gallbladder gangrene/necrosis, perforation, and emphysematous cholecystitis, may be fatal without emergency cholecystectomy. Gallbladder perforation  (<a class="graphic graphic_diagnosticimage graphicRef86867" href="/d/graphic/86867.html" rel="external">image 1</a> and <a class="graphic graphic_diagnosticimage graphicRef86865" href="/d/graphic/86865.html" rel="external">image 2</a>) and emphysematous cholecystitis  (<a class="graphic graphic_diagnosticimage graphicRef56763" href="/d/graphic/56763.html" rel="external">image 3</a>) can usually be detected on imaging studies. </p><p>Gallbladder gangrene/necrosis is more difficult to distinguish from nongangrenous cholecystitis by radiology. There is no imaging sign that is specific for gallbladder gangrene/necrosis [<a href="#rid17">17</a>]. Multiple models have been proposed to predict gallbladder gangrene based on patient history (old age, male sex, coronary artery disease, diabetes), physical examination (tachycardia, guarding on abdominal palpation), laboratory values (leukocytosis, elevated levels of C-reactive protein, bilirubin, urea, and creatinine), and imaging findings (gallbladder wall thickening, pericholecystic fluid) [<a href="#rid18">18-21</a>]. Despite all that, surgeons diagnosed gangrenous cholecystitis preoperatively in only 9 percent of cases [<a href="#rid21">21</a>]. </p><p class="headingAnchor" id="H495923831"><span class="h2">Disease progression</span><span class="headingEndMark"> — </span>Progressive symptoms and signs such as high fever, hemodynamic instability, or intractable pain in spite of best supportive care (including antibiotics and gallbladder drainage) indicate disease progression, which is a sign of gallbladder gangrene and an indication for emergency cholecystectomy to prevent further complications (eg, gallbladder perforation) or sepsis. (See <a class="local">'Ineffective drainage'</a> below.)</p><p class="headingAnchor" id="H1053980"><span class="h1">RISK STRATIFICATION</span><span class="headingEndMark"> — </span>Laparoscopic cholecystectomy is the gold-standard treatment for patients with acute calculous cholecystitis (ACC). Patients who do not require emergency surgery for complicated ACC should be risk stratified to determine if they should undergo early (same-admission) or delayed gallbladder surgery after initial nonoperative management. </p><p>Several systems have been developed to risk stratify patients with ACC with the goals of determining the need and candidacy for early cholecystectomy. As examples, the Tokyo Guidelines (TG) 2013 and 2018 classify patients into grade I (mild), II (moderate), or III (severe) cholecystitis [<a href="#rid22">22</a>]; the American Association of Surgery of Trauma (AAST) system grades patients from I to V [<a href="#rid23">23</a>]. However, a 2020 systematic review and meta-analysis found that none of the prognostic factors and risk prediction models can be relied upon to accurately predict outcomes of ACC [<a href="#rid24">24</a>]. The prognostic factors evaluated include patient sex, age, TG2013 severity class, previous upper abdominal surgery, diabetes, hypertension, and C-reactive protein value. </p><p>Nevertheless, with improvements in experience, surgical technique, and instrumentation, the hesitation to safely perform laparoscopic cholecystectomy in patients with ACC has waned over the years. The contemporary trend emphasizes the pivotal role of early (same-admission) laparoscopic cholecystectomy in the management of ACC, even in high-risk patients: </p><p class="bulletIndent1"><span class="glyph">●</span>TG2018 widened the indications for laparoscopic cholecystectomy when compared with TG2013 [<a href="#rid25">25</a>] by supporting same-admission laparoscopic cholecystectomy for patients with all three severity grades of acute cholecystitis [<a href="#rid1">1</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The 2020 World Society of Emergency Surgery (WSES) guidelines stated that laparoscopic cholecystectomy should be attempted in cases of ACC except in critical patient conditions, such as septic shock or anesthetic contraindications [<a href="#rid26">26</a>].</p><p></p><p>Contemporary studies have further addressed certain patient populations who are traditionally considered high risk for cholecystectomy [<a href="#rid26">26,27</a>]. These include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with liver cirrhosis</strong> – In cirrhotic patients, the morbidity associated with laparoscopic cholecystectomy is directly related to the liver disease [<a href="#rid28">28</a>]. For Child A and B patients (or Model for End-stage Liver Disease [MELD] score &lt;15), laparoscopic cholecystectomy should be the first choice for ACC. In such patients, however, there remains a risk of hepatic decompensation postcholecystectomy and more frequent need for conversion to an open cholecystomy [<a href="#rid29">29</a>]. For patients with Child C or uncompensated cirrhosis, cholecystectomy should be avoided in favor of conservative management [<a href="#rid30">30</a>]. It should be noted that there has been no study on ACC in cirrhotic patients, and the above suggestions are made by extrapolating data from elective cholecystectomy. (See  <a class="medical medical_review" href="/d/html/109437.html" rel="external">"Managing the difficult gallbladder", section on 'Cirrhosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Older adult patients</strong> – Initial nonoperative management with delayed cholecystectomy has traditionally been used as an alternative strategy to immediate cholecystectomy for older patients (eg, &gt;65 years) [<a href="#rid31">31</a>]. However, data have consistently shown that outcomes following early laparoscopic cholecystectomy in octogenarians are comparable with those for younger patients [<a href="#rid32">32-35</a>]. According to the 2017 WSES and Italian Society for Geriatric Surgery guidelines for older patients with ACC, early laparoscopic cholecystectomy can be performed in older adult patients with ACC, even in those &gt;80 years of age [<a href="#rid36">36</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a United Kingdom (UK) retrospective study of 47,500 patients &gt;80 years who were admitted as an emergency with acute cholecystitis, early cholecystectomy was associated with higher 30 day mortality rate (11.6 versus 9.9 percent) but lower one-year mortality rate (20.8 versus 27.1 percent) and readmission rate compared with conservative management [<a href="#rid37">37</a>]. Cholecystostomy was associated with higher mortality than both cholecystectomy and conservative management (13.4 and 35 percent at 30 days and one year). Laparoscopic cholecystectomy was associated with lower 30 day mortality than open cholecystectomy (odds ratio [OR] 0.16, 95% CI 0.10-0.25). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A separate database study of 29,818 older adult patients (aged ≥66 years) with acute cholecystitis found a higher mortality over the following two years in patients who were discharged without surgery compared with patients who underwent cholecystectomy in the initial hospitalization (hazard ratio [HR] 1.56, 95% CI 1.47-1.65). In addition, 38 percent of patients who were discharged without cholecystectomy were readmitted within two years for gallstone-related events, compared with 4 percent who underwent cholecystectomy during the index admission [<a href="#rid38">38</a>]. </p><p></p><p class="bulletIndent1">Other studies reported that cholecystectomy can be performed in octogenarian patients with ACC, albeit at higher morbidity and mortality rates (up to 41 and 5 percent, respectively) compared with younger patients [<a href="#rid32">32,39,40</a>]. (See <a class="local">'Morbidity and mortality'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients who are pregnant</strong> – Following supportive care including antibiotic therapy, gallbladder surgery is indicated for any pregnant patient with acute cholecystitis and can be safely performed during any trimester  (<a class="graphic graphic_algorithm graphicRef131757" href="/d/graphic/131757.html" rel="external">algorithm 1</a>). For patients near term, a reasonable alternative is to defer gallbladder surgery until after delivery, assuming that symptoms can be controlled with antibiotics and supportive care. However, the risk of persistent, worsening, or recurrent symptoms in such patients is unknown. For pregnant patients who undergo cholecystectomy, we suggest a laparoscopic approach rather than open surgery, when feasible and available. Laparoscopic surgery has been shown to improve patient outcomes without increasing surgical, maternal, or fetal complication rates. (See  <a class="medical medical_review" href="/d/html/15095.html" rel="external">"Gallstone diseases in pregnancy"</a>.)</p><p></p><p>As such, the decision to perform early cholecystectomy in patients with uncomplicated ACC comes down to whether the surgeon considers them suitable surgical candidates. Besides the obvious reasons not to perform cholecystectomy (eg, septic shock or anesthetic contraindication), the criteria for a suitable surgical candidate have not been universally defined and depend on the judgment of the surgeon and anesthesia provider  (<a class="graphic graphic_algorithm graphicRef64526" href="/d/graphic/64526.html" rel="external">algorithm 2</a>). As examples, high-risk patients were defined as having APACHE scores between 7 and 14 in the CHOCOLATE trial, and such patients did better with cholecystectomy than percutaneous cholecystostomy [<a href="#rid41">41</a>]. Alternatively, the American Society of Anesthesiology (ASA) physical status classification may be used to help stratify patients for surgery risk, with ASA class I to III considered good surgical candidates and class IV or V considered poor candidates. Local clinical pathways should be developed to define the patient criteria that fit local needs and expertise [<a href="#rid26">26</a>]. </p><p class="headingAnchor" id="H5"><span class="h1">GOOD SURGICAL CANDIDATES</span><span class="headingEndMark"> — </span>For good surgical candidates with acute calculous cholecystitis (ACC) but without indications for emergency cholecystectomy, we recommend cholecystectomy during the initial hospitalization  (<a class="graphic graphic_algorithm graphicRef64526" href="/d/graphic/64526.html" rel="external">algorithm 2</a>). Early cholecystectomy has been shown to eliminate recurrent gallstone-related diseases that occur in one-third to one-half of those ACC patients who are managed conservatively, and it can be safely performed in patients traditionally considered high risk. (See <a class="local">'Risk stratification'</a> above.)</p><p>No randomized trials have been performed that directly compared early cholecystectomy with conservative management in patients with ACC [<a href="#rid26">26</a>]. In a randomized trial that compared <strong>delayed</strong> cholecystectomy with observation with a median follow-up of 67 months, about 30 percent of patients treated conservatively developed recurrent gallstone-related complications, compared with 3 percent of those who underwent cholecystectomy, and 60 percent of patients required cholecystectomy subsequently [<a href="#rid42">42</a>]. The study only included 33 patients in the observation group and had a high risk of bias [<a href="#rid43">43</a>]. </p><p>Early cholecystectomy has been compared with cholecystostomy in another randomized trial (CHOCOLATE). One hundred and forty-two patients with symptoms of ACC for fewer than seven days and who were at high risk for surgery (defined by an APACHE II score between 7 and 14) were randomly assigned to immediate laparoscopic cholecystectomy or percutaneous catheter drainage [<a href="#rid41">41</a>]. Cholecystectomy was completed laparoscopically in 83 percent; 17 percent converted to open. Major complications occurred in 12 percent of patients who underwent surgery, including bile duct injury in 6 percent. By contrast, major complications occurred in 65 percent of those treated with percutaneous drainage, of which the majority were related to recurrent biliary disease (53 percent) or drain malfunction. The one-year mortality rate was 3 and 9 percent after cholecystectomy and percutaneous drainage, respectively (p = 0.27).</p><p>In a 2022 systematic review and meta-analysis of six studies, compared with laparoscopic cholecystectomy, percutaneous drainage was associated with higher rates of mortality (relative risk [RR] 7.47, 95% CI 1.88-29.72), morbidity (RR 3.71, 95% CI 1.78-7.75), readmission (RR 7.91, 95% CI 3.80-16.49), and longer length of hospitalization (weighed mean difference [WMD] 6.92, 95% CI 5.89-7.95) [<a href="#rid44">44</a>]. </p><p>Although Tokyo Guidelines (TG) 2013 grade 3 ACC was associated with higher mortality than grade I ACC when treated with cholecystectomy [<a href="#rid24">24</a>], a retrospective case series reported success with immediate cholecystectomy in 93 percent of patients with grade II (moderate) and 64 percent with grade III (severe) acute cholecystitis according to the 2013 TG; the surgical morbidity and mortality rates were comparable between grade I (mild) and II patients [<a href="#rid45">45</a>]. For patients with severe ACC, transfer to high-volume or specialized centers may be warranted and has been shown to reduce complication and mortality rates [<a href="#rid46">46,47</a>].</p><p class="headingAnchor" id="H1054419"><span class="h2">Timing of cholecystectomy</span><span class="headingEndMark"> — </span>For suitable surgical candidates, laparoscopic cholecystectomy should be performed as early as possible during the hospitalization. Although all agree that earlier cholecystectomy is associated with lower perioperative morbidity and mortality, there is no consensus as to how early surgery needs to happen. Various authors or societies have advocated performing cholecystectomy within 3, 7, and 10 days of admission or symptom onset or else delaying surgery for a period of time (eg, 45 days) to allow inflammation to subside. The authors of this topic prefer to perform surgery within the first three days.</p><p>The timing of cholecystectomy in patients presenting with ACC has been under intense investigation, with "early" cholecystectomy variably defined in the literature as gallbladder surgery performed within 3, 7, or 10 days of symptom onset and "delayed" cholecystectomy as that performed 7 or 45 days, or six weeks, after initial diagnosis [<a href="#rid48">48</a>]. Evidence from large database reviews and randomized trials generally associates cholecystectomy performed early during the initial hospitalization with better outcomes and a lower cost [<a href="#rid38">38,49-60</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>A 2016 systematic review and meta-analysis included seven meta-analyses comparing early (within seven days of the onset of symptoms) with delayed laparoscopic cholecystectomy (at least one week after initial conservative treatment) for ACC published between 2004 and 2015 [<a href="#rid61">61</a>]. Although the seven individual meta-analyses (all of which only included randomized trials [ranging from 3 to 15]) reported discordant results [<a href="#rid62">62,63</a>], the "meta-meta-analysis" concluded that no differences in mortality, bile duct injury, bile leakage, overall complications, or conversion to open surgery were seen. However, early cholecystectomy was associated with a significant reduction in wound infection, length of hospitalization, and duration of surgery and improvement in quality of life.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A large administrative database study of over 15,000 cholecystectomies for acute cholecystitis provided even more granular data on how the timing of cholecystectomy can impact patient outcomes [<a href="#rid64">64</a>]. In that study, the rate of intraoperatively detected biliary injury was the lowest in patients who underwent surgery on the day of admission; the rate increased day by day thereafter. The rates of other intraoperative adverse events (eg, bleeding), as well as 30 and 90 day mortality rates, were lower in patients who underwent surgery on the first or second day after admission than either on the day of admission or after the second day after admission. The authors of the study advocated operating within two days of admission, but after patients have been adequately resuscitated, and when the most qualified surgeon becomes available. Although there were no data, they speculated that the slightly higher rate of nonbiliary adverse events that occurred when patients underwent surgery on the day of admission compared with the day after was due to under-resuscitation of the patient or a lack of laparoscopic surgical expertise. Alternatively, the rate of adverse events may be influenced by the duration of symptoms rather than hospitalization. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Similarly, a 2020 study of more than 109,862 cholecystectomies performed in New York State found that patients who underwent cholecystectomy &lt;72 hours from admission had a lower conversion rate to an open procedure (7.5 versus 13.8 percent, P&lt;0.001) than those who underwent cholecystectomy &gt;72 hours after admission [<a href="#rid65">65</a>].</p><p></p><p>Early surgery is easier to perform as local inflammation increases after 72 hours from the initial onset of symptoms, making dissection less precise, increasing the severity of surgical complications, and making open conversion more likely. </p><p>Nevertheless, there are data to suggest that surgery is still safe even after 72 hours from symptom onset, albeit with a higher rate of conversion from laparoscopic to open technique [<a href="#rid57">57,66-68</a>]. In a randomized trial of 86 patients with acute cholecystitis who had more than 72 hours of symptoms, early laparoscopic cholecystectomy during the index admission was safe [<a href="#rid69">69</a>]. Of 42 patients who received early surgery, only one required conversion to open surgery; none had a bile leak or bile duct injury. Compared with surgery delayed for six weeks, early surgery reduced the overall morbidity rate from 39 to 14 percent. Given that the postoperative complication rates (15 percent early versus 17 percent delayed) were similar, the difference in morbidity was almost entirely attributed to complications that occurred while patients who underwent delayed surgery were waiting for surgery (3 failed initial treatment; 10 required unplanned readmission while awaiting surgery). The length of stay (four versus seven days), duration of antibiotic therapy (2 versus 10 days), and total hospital cost (€9349 versus €12,361) were also in favor of early surgery. The authors of this trial argued that the degree of inflammatory changes associated with acute cholecystitis may not be time dependent as previously thought [<a href="#rid70">70</a>] and therefore suggested that early laparoscopic cholecystectomy may be offered to patients with acute cholecystitis regardless of the duration of symptoms. </p><p>Although the 2013 Tokyo Guidelines suggested that surgery be performed within 72 hours of symptom onset, it is not always practical, as some patients present after more than three days of symptoms [<a href="#rid25">25</a>]. The updated 2018 Tokyo Guidelines concluded that in patients for whom more than 72 hours has passed since symptom onset, there are still benefits to performing cholecystectomy early, and recommended early cholecystectomy in low-risk patients with ACC regardless of how much time has passed since symptom onset [<a href="#rid1">1</a>].</p><p>The 2020 World Society of Emergency Surgery (WSES) guidelines recommended early laparoscopic cholecystectomy for ACC as long as it can be completed within 7 days of admission and 10 days of symptom onset [<a href="#rid26">26</a>]. Patients who have had symptoms for longer than 10 days should not undergo early cholecystectomy unless their disease progresses; delaying cholecystectomy beyond six weeks is a safer option for those patients to allow inflammation to subside. </p><p class="headingAnchor" id="H1054590"><span class="h2">Surgical approach</span><span class="headingEndMark"> — </span>For surgical treatment of patients with ACC, we recommend laparoscopic cholecystectomy rather than open cholecystectomy. Laparoscopic cholecystectomy should be attempted unless there is an absolute anesthetic contraindication to laparoscopy or a lack of requisite surgical expertise.</p><p>In a systematic review and meta-analysis of 10 trials comparing open versus laparoscopic cholecystectomy for acute cholecystitis, laparoscopic surgery was associated with lower mortality (odds ratio [OR] 0.2), morbidity (OR 0.46), postoperative wound infection (OR 0.54) and pneumonia rates (OR 0.51), and hospital length of stay (median difference -4.74 days) [<a href="#rid71">71</a>]. There were no significant differences in the bile leakage rate, intraoperative blood loss, and operative times. Conversion rate ranged from 8 to 35 percent.</p><p>However, laparoscopic cholecystectomy for acute cholecystitis can be more technically demanding than surgery for other gallbladder diseases (eg, biliary colic). When faced with severe inflammation, adhesion, or bleeding in the Calot's triangle, or suspected bile duct injury, surgeons should be prepared to perform an alternative technique, such as subtotal cholecystectomy, top-down cholecystectomy, or conversion to open surgery, to ensure safe dissection [<a href="#rid72">72-74</a>]. Techniques that can be used to manage a "difficult" gallbladder are discussed in another topic. (See  <a class="medical medical_review" href="/d/html/109437.html" rel="external">"Managing the difficult gallbladder"</a>.) </p><p>Although other minimally invasive techniques such as single-incision laparoscopy, mini-laparoscopy, robotic-assisted laparoscopy, and natural orifice transluminal endoscopic surgery (NOTES) have been used to treat patients with symptomatic cholelithiasis, their role in the treatment of patients with acute cholecystitis is limited due to the technically demanding dissection caused by severe inflammation as well as technical challenges associated with the adoption of these new technologies [<a href="#rid74">74,75</a>]. (See  <a class="medical medical_review" href="/d/html/3685.html" rel="external">"Laparoscopic cholecystectomy", section on 'Abdominal access'</a>.)</p><p class="headingAnchor" id="H6"><span class="h1">POOR SURGICAL CANDIDATES</span><span class="headingEndMark"> — </span>For poor surgical candidates with acute calculous cholecystitis (ACC) but without indications for emergency cholecystectomy, we suggest initial nonoperative management rather than immediate cholecystectomy  (<a class="graphic graphic_algorithm graphicRef64526" href="/d/graphic/64526.html" rel="external">algorithm 2</a>). As examples, conservative management with or without cholecystostomy is required for patients who are in septic shock or have cardiopulmonary contraindications to anesthesia. Best medical therapy is likely to be safe but may incur a high incidence of recurrent disease [<a href="#rid42">42</a>].</p><p>Nonoperative management consists of antibiotics for all patients and gallbladder drainage for some patients. Septic patients should undergo urgent gallbladder drainage; removing the infected bile or pus from the gallbladder could potentially reverse sepsis. Patients who fail to improve with antibiotic therapy for one to three days also require gallbladder drainage. Failure to improve after three days of biliary drainage requires careful reassessment for drain positioning or development of new infectious pockets of liver abscess, and patients may require cholecystectomy despite the high risk or else face a dismal prognosis. (See <a class="local">'Ineffective drainage'</a> below.) </p><p>Once cholecystitis resolves, the patient's risk for surgery should be reassessed. Patients who have become reasonable candidates for surgery should undergo delayed (elective) cholecystectomy [<a href="#rid76">76</a>]. Others with a higher operative risk can be considered for percutaneous gallstone extraction with or without mechanical lithotripsy (see  <a class="medical medical_review" href="/d/html/670.html" rel="external">"Overview of nonsurgical management of gallbladder stones"</a>). Medical management with interval cholecystectomy only for recurrent acute cholecystitis may also be appropriate [<a href="#rid31">31</a>]. (See <a class="local">'Effective drainage'</a> below.)</p><p class="headingAnchor" id="H1937215"><span class="h2">Antibiotic therapy</span><span class="headingEndMark"> — </span>Cholecystectomy in high-risk patients carries a mortality rate of up to 19 percent [<a href="#rid77">77</a>]. In such patients, the potential risk of cholecystectomy likely outweighs its benefits, and an initial nonoperative approach should be undertaken that includes antibiotic therapy and bowel rest. (See <a class="local">'Supportive care'</a> above.)</p><p>Appropriate antibiotics should be administered to patients in septic shock within one hour of diagnosis and to others within six hours [<a href="#rid14">14</a>]. The primary goals of antimicrobial therapy in acute cholecystitis are to limit both the local inflammation and systemic septic response and to prevent intrahepatic and pericholecystic abscess formation. The antimicrobial agents that are appropriate for treating acute cholecystitis are the same whether or not a cholecystectomy is planned as discussed above. (See <a class="local">'Antibiotics'</a> above.)</p><p>While antibiotics are generally stopped the day after surgery in patients who undergo cholecystectomy (ie, source control) unless there is ongoing sepsis, the optimal duration of antimicrobial therapy for those managed nonoperatively is not known and requires clinical judgment. For patients who improve, we typically treat until the signs and symptoms of acute cholecystitis have resolved. Intravenous antibiotics can be converted to oral formulation (eg, <a class="drug drug_general" data-topicid="8676" href="/d/drug information/8676.html" rel="external">amoxicillin-clavulanate</a>, <a class="drug drug_general" data-topicid="9231" href="/d/drug information/9231.html" rel="external">cephalexin</a> plus <a class="drug drug_general" data-topicid="9646" href="/d/drug information/9646.html" rel="external">metronidazole</a>, or fluoroquinolone plus metronidazole) when the patient can tolerate an oral diet [<a href="#rid14">14</a>]. Patients who do not respond to antibiotic therapy and supportive care for one to three days require additional interventions such as gallbladder drainage or surgery. (See <a class="local">'Gallbladder drainage'</a> below.)</p><p class="headingAnchor" id="H5146500"><span class="h2">Gallbladder drainage</span><span class="headingEndMark"> — </span>Some form of gallbladder drainage is required as the initial treatment, in conjunction with antibiotics, for patients who are septic or critically ill [<a href="#rid14">14,78-81</a>]. Gallbladder drainage is also suggested for patients managed nonoperatively who show disease progression or no appreciable clinical improvement after one to three days of nonoperative management with antibiotics [<a href="#rid82">82</a>]. </p><p>Gallbladder drainage decompresses infected bile or pus from the gallbladder and allows both local inflammation and systemic illness to resolve before gallbladder removal can be accomplished at a lower risk to the patient at a later time. Gallbladder drainage can be accomplished via percutaneous or endoscopic methods. Percutaneous transhepatic drainage is generally preferred due to its ease, safety, and reduced costs, but endoscopic drainage methods may be employed when the requisite expertise is available [<a href="#rid26">26</a>]. </p><p>Percutaneous drainage has been compared with endoscopic drainage in multiple observational studies [<a href="#rid83">83</a>] and meta-analyses [<a href="#rid84">84,85</a>]. In general, percutaneous drainage has the highest technical success rate. However, in some studies, the clinical success rate of endoscopic ultrasound-guided transmural drainage can be higher, and the complication and reintervention rates lower, than those of percutaneous drainage, due to the widespread use of lumen-apposing metal stents with flare ends that are more secure than double pigtail catheters [<a href="#rid85">85</a>]. Transpapillary drainage generally has the lowest success rate due to technical difficulties in cannulating the cystic duct. The safety profiles differ between the different drainage methods: significant risk of perforation and bleeding can be expected with transmural endoscopic drainage, and acute pancreatitis risk is significantly higher with transpapillary drainage, while percutaneous drainage is associated with significantly higher chances of disease recurrence and percutaneous drainage catheter dislodgement [<a href="#rid85">85</a>]. The overall rate of complications, however, varies between studies.</p><p class="headingAnchor" id="H1055781"><span class="h3">Percutaneous</span><span class="headingEndMark"> — </span>Percutaneous cholecystostomy is an option for patients with acute cholecystitis who have all of the following [<a href="#rid75">75</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Contraindications to general anesthesia and/or high surgical risk</p><p class="bulletIndent1"><span class="glyph">●</span>No coagulopathy or bleeding disorders</p><p class="bulletIndent1"><span class="glyph">●</span>Late presentation (&gt;72 hours after onset of symptoms)</p><p class="bulletIndent1"><span class="glyph">●</span>Failure of medical (antibiotic) therapy</p><p></p><p>The optimal timing for percutaneous cholecystostomy is debated. However, one retrospective study showed that early placement (&lt;24 hours from symptom onset) was associated with a lower procedure-related bleeding rate (0 versus 5 percent) and a shorter hospital stay (15 versus 21 days) compared with late placement (&gt;24 hours from symptom onset) [<a href="#rid86">86</a>]. </p><p>The timing of percutaneous cholecystostomy likely depends on its clinical indication. We suggest urgent percutaneous cholecystostomy tube placement in high-surgical-risk septic or critically ill patients with acute cholecystitis. For others who are being managed nonsurgically for ACC but are not critically ill, we place a cholecystostomy tube if the patient does not demonstrate clinical improvement after one to three days of antibiotic therapy. In most published studies, patients who respond to antibiotics do so within three days [<a href="#rid82">82,87</a>]. This practice also takes into consideration the fact that as a radiologic procedure, percutaneous cholecystostomy may not be readily available at nights and on weekends in all facilities. </p><p>Percutaneous cholecystostomy resolves acute cholecystitis in approximately 85 percent of patients [<a href="#rid77">77</a>] as indicated by resolution of fever, abdominal pain, and inflammatory markers. The technical success rates range from 82 to 100 percent in various series [<a href="#rid78">78-81,88</a>]. Minor complications include bleeding, catheter blockage and dislodgement (10 to 15 percent), and failure to resolve the acute cholecystitis (10 percent) [<a href="#rid79">79,81,89</a>]. In one study, major bleeding complications occurred rarely (0.4 percent) and were no different between patients with and without coagulopathy [<a href="#rid89">89</a>]. Failure is usually related to ineffective drainage due to thick sludge or pus. We generally irrigate the gallbladder contents manually with normal <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> through the catheter. If irrigation is ineffective, the percutaneous pigtail catheter can be replaced over a wire with a larger one to achieve more effective irrigation.</p><p>Although percutaneous cholecystostomy is the most widely used and studied method of nonsurgical gallbladder drainage, there is no high-quality evidence supporting its use as a definitive therapy for ACC [<a href="#rid90">90</a>], nor has any study demonstrated its superiority over either antibiotic treatment or early cholecystectomy [<a href="#rid82">82,91,92</a>]. As an example, in a trial of 123 high-risk patients with acute cholecystitis who underwent percutaneous cholecystostomy or antibiotic therapy, a similar percentage of patients in each group had resolution of their symptoms (86 versus 87 percent). All successfully treated patients showed clinical improvement within the first three days [<a href="#rid82">82</a>]. In the CHOCOLATE trial cited above, high-risk patients who underwent early cholecystectomy had better outcomes than those who underwent percutaneous drainage [<a href="#rid41">41</a>]. (See <a class="local">'Risk stratification'</a> above.)</p><p>In some retrospective and database studies, higher or lower mortality and morbidity rates have been associated with percutaneous cholecystostomy treatment of acute cholecystitis compared with cholecystectomy [<a href="#rid93">93-96</a>]. This difference is likely due to patient selection bias as patients who underwent percutaneous cholecystostomy were usually older and had a higher American Society of Anesthesiologists (ASA) classification, more comorbidities, longer hospital stay, more complications, and more readmissions. In two studies of medicare provider claims, percutaneous cholecystostomy has increased from 0.3 percent (1994) to 2.9 percent (2009) to 6.1 percent (2018) of all gallbladder procedures [<a href="#rid97">97,98</a>]. </p><p class="headingAnchor" id="H1055793"><span class="h3">Endoscopic</span><span class="headingEndMark"> — </span>Endoscopic gallbladder drainage can be performed in patients with acute cholecystitis in whom percutaneous approaches are contraindicated or are not anatomically feasible (ie, advanced liver disease, ascites, or coagulopathy) [<a href="#rid75">75,99,100</a>]. Two different techniques, transpapillary drainage and transmural drainage, are available, depending on local expertise [<a href="#rid75">75</a>].</p><p class="headingAnchor" id="H14805485"><span class="h4">Transpapillary drainage</span><span class="headingEndMark"> — </span>Transpapillary drainage utilizes endoscopic retrograde cholangiography (ERCP) techniques and equipment to place a drainage catheter into the gallbladder via the cystic duct. The other end of the catheter is either brought out through the nose (nasobiliary drain) or left to drain internally into the duodenum. The technical and clinical success rate of the two techniques are comparable [<a href="#rid101">101,102</a>]. </p><p>When technically successful (in approximately 76 to 94 percent of patients), transpapillary drainage resolves acute cholecystitis in 80 to 90 percent of patients, including those with advanced liver cirrhosis [<a href="#rid103">103-105</a>]. However, this technique can be technically challenging because the cystic duct is often narrow and tortuous. In addition, this procedure has all the inherent and occasionally serious complications associated with ERCP (eg, postsphincterotomy bleeding). (See  <a class="medical medical_review" href="/d/html/632.html" rel="external">"Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults"</a>.)</p><p class="headingAnchor" id="H14805492"><span class="h4">Transmural drainage</span><span class="headingEndMark"> — </span>Transmural drainage utilizes endoscopic ultrasound guidance to access the inflamed gallbladder with a needle puncture, followed by dilation and stent placement over a guidewire. The introduction of self-expandable, covered, lumen-apposing metal stents allows large-caliber (10 to 15 mm) direct endoscopic access to the gallbladder for decompression and stone removal [<a href="#rid106">106</a>]. The transmural drainage technique is technically successful in most cases (97 percent) and resolves acute cholecystitis in over 95 percent of patients [<a href="#rid107">107,108</a>]. </p><p>In a 2020 randomized trial of 80 patients with very high risk for cholecystectomy, endoscopic ultrasound-guided and percutaneous gallbladder drain resulted in similar technical (97 versus 100 percent) and clinical success rates (92 versus 92 percent) and mortality (7.7 versus 10 percent) [<a href="#rid109">109</a>]. Compared with percutaneous drainage, endoscopic ultrasound-guided drainage was associated with reduced one-year adverse events (26 versus 78 percent), 30 day adverse events (13 versus 48 percent), reinterventions after 30 days (2.6 versus 30 percent), number of unplanned readmissions (15 versus 50 percent), recurrent cholecystitis (3 versus 20 percent), and postprocedural pain scores and analgesic requirements.</p><p>Endoscopic transmural drainage is used as a bridge to definitive gallbladder surgery. However, the adhesion created between the gallbladder and duodenum/stomach may interfere with future cholecystectomy surgery.</p><p class="headingAnchor" id="H5146535"><span class="h2">Subsequent care following drainage</span><span class="headingEndMark"> — </span>For patients who undergo gallbladder drainage, subsequent care depends on whether their clinical symptoms resolve after the procedure  (<a class="graphic graphic_algorithm graphicRef64526" href="/d/graphic/64526.html" rel="external">algorithm 2</a>).</p><p class="headingAnchor" id="H1937106"><span class="h3">Effective drainage</span><span class="headingEndMark"> — </span>The risk of recurrent biliary disease following percutaneous gallbladder drainage is between 19 to 41 percent [<a href="#rid110">110-112</a>]. In one study, 14, 19, and 29 percent of patients who were treated nonoperatively for ACC developed gallstone-related events at six weeks, 12 weeks, and one year, including biliary colic (70 percent), biliary obstruction (24 percent), and pancreatitis (6 percent) [<a href="#rid113">113</a>]. About half of the patients who did not undergo cholecystectomy after percutaneous gallbladder drainage were readmitted within one year, and 1 percent died while in the hospital [<a href="#rid113">113</a>].</p><p>As such, once cholecystitis resolves with nonoperative treatment, we suggest reassessing the patient's risk for surgery and offering cholecystectomy to reasonable surgical candidates. Percutaneous stone extraction or medical management is appropriate for those who continue to be poor or nonsurgical candidates. </p><p class="headingAnchor" id="H1717854603"><span class="h4">Surgical candidates</span><span class="headingEndMark"> — </span>In the context of ACC, gallbladder drainage is generally accepted as a bridge to definitive therapy, which remains cholecystectomy [<a href="#rid114">114</a>]. The risk for surgery should be reconsidered once cholecystitis resolves in patients treated nonoperatively with antibiotics and possibly gallbladder drainage. Patients who have become reasonable candidates for surgery should undergo elective cholecystectomy. Laparoscopic cholecystectomy is preferred in those who require surgery. </p><p>The timing of cholecystectomy after gallbladder drainage is dictated by a number of clinical and nonclinical factors, ranging from immediately after clinical improvement to after eight weeks. In a small randomized trial involving 61 patients with acute cholecystitis treated initially with percutaneous cholecystostomy, all patients achieved symptomatic relief within 24 hours [<a href="#rid91">91</a>]. Both early and delayed laparoscopic cholecystectomy were feasible in the majority of patients (94 percent early versus 87 percent delayed); the average length of stay and cost were lower with early cholecystectomy.</p><p class="headingAnchor" id="H970337042"><span class="h4">Nonsurgical candidates</span><span class="headingEndMark"> — </span>Although percutaneous cholecystostomy is often performed as a bridge to surgery, 43 to 94 percent of patients did not undergo cholecystectomy after gallbladder drainage in published series, most often due to ongoing contraindications to surgery [<a href="#rid114">114-116</a>]. Patients who stabilize but continue to be high risk for surgery can be considered for percutaneous gallstone extraction with or without mechanical lithotripsy [<a href="#rid117">117</a>]. Alternatively, medical management with interval cholecystectomy only for recurrent acute cholecystitis may be appropriate [<a href="#rid31">31</a>]. (See  <a class="medical medical_review" href="/d/html/670.html" rel="external">"Overview of nonsurgical management of gallbladder stones"</a>.)</p><p class="headingAnchor" id="H447677665"><span class="h4">Tube management</span><span class="headingEndMark"> — </span>For potential surgical candidates, we prefer to keep the percutaneous cholecystostomy tube in situ until the patient undergoes cholecystectomy. In patients with calculous cholecystitis, the risk of recurrent symptoms can be as high as 20 percent within one year [<a href="#rid86">86</a>]. Maintaining adequate gallbladder drainage minimizes the risk of recurrent cholecystitis, which could further delay or complicate gallbladder surgery.</p><p>We perform a tube study to assess the patency of the cystic duct. If the cystic duct is patent, we cap the percutaneous cholecystostomy tube, which is more convenient for the patient than gravity drainage and also preserves the bile acid pool. The bile acid pool can be depleted by long-standing cholecystostomy tube drainage, which can lead to intrahepatic cholestasis and a rise in liver function tests. </p><p>The management of the percutaneous cholecystostomy tube in patients who will not undergo definitive gallbladder surgery is highly variable and not evidence based. In a systematic review of 50 studies, the timing of tube removal ranged from 2 to 193 days, with no correlation between tube duration and clinical outcomes [<a href="#rid118">118</a>].</p><p>Where available, percutaneous gallstone extraction with or without mechanical lithotripsy is performed via the cholecystostomy tube. The ritual just before tube removal is also highly variable: while some authors cap the tube for a few days before removal, others allow several weeks of tube drainage with the patient on oral bile acid supplement (to prevent depletion) before removal. Most would perform a tube study to ensure cystic duct patency before removing the tube. </p><p>A common cause of catheter failure relates to its internal pigtail tugging on the gallbladder wall in cases when the catheter is sutured or fixed with tape or a clamp to the skin very close to the percutaneous entry hole. This prevents the catheter from moving in and out as the gallbladder and liver move up and down with respiration. We do not suture but tape the percutaneous catheter to the skin, leaving a loop of catheter between the tape and the percutaneous entry hole. This allows the catheter to move in and out of the abdominal wall during respiration or if the patient were to stand up when the gallbladder and the liver will move down to some extent due to gravity.</p><p class="headingAnchor" id="H1937127"><span class="h3">Ineffective drainage</span><span class="headingEndMark"> — </span>In the published literature, patients typically demonstrate clinical improvement within one to three days after a gallbladder drainage procedure, regardless of the approach (percutaneous or endoscopic) [<a href="#rid82">82</a>]. Therefore, patients who have not responded in three days after gallbladder drainage likely have progressed to gangrene of the gallbladder, in which case emergency cholecystectomy is mandatory regardless of the surgical risk. (See <a class="local">'Indications for emergency cholecystectomy'</a> above.)</p><p class="headingAnchor" id="H1004316181"><span class="h1">ASSOCIATED COMMON BILE DUCT STONE</span><span class="headingEndMark"> — </span>Five to 15 percent of patients who present with acute calculous cholecystitis (ACC) have associated common bile duct (CBD) stones. Hence, patients should undergo standard preoperative laboratory and imaging tests and/or intraoperative cholangiography to diagnose CBD stones; those who are diagnosed with CBD stones should be treated accordingly with endoscopic or surgical common duct exploration. Diagnosis and treatment of CBD stones are discussed in other topics. (See  <a class="medical medical_review" href="/d/html/13922.html" rel="external">"Choledocholithiasis: Clinical manifestations, diagnosis, and management"</a> and  <a class="medical medical_review" href="/d/html/15093.html" rel="external">"Surgical common bile duct exploration"</a>.)</p><p>An uncommon condition that could occur in the context of acute cholecystitis and mimic CBD stones is Mirizzi syndrome, which occurs in 1 percent of patients with cholelithiasis. Mirizzi syndrome is discussed in a dedicated topic. (See  <a class="medical medical_review" href="/d/html/656.html" rel="external">"Mirizzi syndrome"</a>.)</p><p class="headingAnchor" id="H7"><span class="h1">MORBIDITY AND MORTALITY</span><span class="headingEndMark"> — </span>The overall mortality of a single episode of acute cholecystitis is approximately 3 percent. However, the risk in a given patient depends upon the patient's health and surgical risk [<a href="#rid79">79</a>]. Mortality is less than 1 percent in young, otherwise healthy patients but approaches 10 percent in high-risk patients or those with complications. Perioperative morbidity and mortality associated with specific treatments are reviewed elsewhere. (See  <a class="medical medical_review" href="/d/html/3685.html" rel="external">"Laparoscopic cholecystectomy", section on 'Postoperative complications'</a> and  <a class="medical medical_review" href="/d/html/15096.html" rel="external">"Open cholecystectomy", section on 'Complications of cholecystectomy'</a>.)</p><p>Several studies identified older age as a risk factor for adverse outcomes with cholecystectomy: </p><p class="bulletIndent1"><span class="glyph">●</span>In a database study of low-risk (American Society of Anesthesiologists [ASA] I or II) patients with acute calculous cholecystitis (ACC), the 30 day mortality rate increased with age: 4.5 percent for those 80 years and older, 0.5 percent for those 65 to 79 years, and 0.2 percent for those 50 to 64 years [<a href="#rid119">119</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A 2020 systematic review and meta-analysis of 19 retrospective studies reported higher overall and major complication rates in all age cutoffs [<a href="#rid120">120</a>]. This study reported a sevenfold increase in perioperative mortality, which increased to tenfold in patients ≥80 years. </p><p></p><p>A study of the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database evaluated outcomes following treatment of acute cholecystitis in 5460 patients with and without diabetes [<a href="#rid121">121</a>]. Mortality among 770 patients with diabetes was significantly higher than in the 4690 patients without diabetes (4.4 versus 1.4 percent). The risk for complications, including cardiovascular events and renal failure, was also significantly increased.</p><p class="headingAnchor" id="H669222836"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/116051.html" rel="external">"Society guideline links: Gallbladder surgery"</a> and  <a class="medical medical_society_guidelines" href="/d/html/115384.html" rel="external">"Society guideline links: Cholecystitis and other gallbladder disorders"</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Acute cholecystitis refers to a syndrome of right upper quadrant pain, fever, and leukocytosis associated with gallbladder inflammation, which is usually related to gallstone disease (ie, acute calculous cholecystitis [ACC]). Once a patient is diagnosed with ACC, definitive therapy aimed at eliminating the gallstones is required, or else the likelihood of recurrent symptoms or complications is high. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial care</strong> – Patients with ACC should be admitted to the hospital. Initial supportive care includes intravenous fluid therapy, correction of electrolyte disorders, and control of pain. Adequate pain control can usually be achieved with nonsteroidal anti-inflammatory drugs (NSAIDs) or opioids. (See <a class="local">'Supportive care'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antibiotics</strong> – Acute cholecystitis is primarily an inflammatory process, but secondary infection of the gallbladder can occur as a result of cystic duct obstruction and bile stasis. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For patients with complicated ACC, broad-spectrum antibiotics are required.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For patients with uncomplicated ACC, we also suggest empiric antibiotic therapy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). </p><p></p><p class="bulletIndent2">Once started, antibiotics should generally be continued until either 24 hours after the gallbladder is removed or the cholecystitis has resolved clinically. (See <a class="local">'Antibiotics'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definitive care</strong> – The choice and timing of intervention for ACC (cholecystectomy, gallbladder drainage) depend upon the severity of symptoms and the patient's overall risk of surgery  (<a class="graphic graphic_algorithm graphicRef64526" href="/d/graphic/64526.html" rel="external">algorithm 2</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Indications for</strong> <strong>emergency cholecystectomy</strong> – Regardless of surgical risk, patients require urgent cholecystectomy if they have (see <a class="local">'Indications for emergency cholecystectomy'</a> above): </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Suspicion of complicated acute cholecystitis such as gallbladder gangrene/necrosis or gallbladder perforation, or emphysematous cholecystitis.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Progressive symptoms and signs such as high fever, hemodynamic instability, or intractable pain in spite of adequate antimicrobial therapy and gallbladder drainage.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Good surgical candidates</strong> – For good surgical candidates with ACC but without indications for emergency cholecystectomy, we recommend cholecystectomy during the initial hospitalization rather than nonoperative management (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). Surgery should be performed as early as possible, preferably within three days of symptom onset. Cholecystectomy performed earlier rather than later in the hospitalization has been associated with reduced perioperative morbidity and mortality. (See <a class="local">'Good surgical candidates'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Poor surgical candidates</strong> – For poor surgical candidates with ACC but without indications for emergency cholecystectomy, we suggest initial nonoperative management rather than cholecystectomy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). These include patients who are in septic shock or have cardiopulmonary contraindications to anesthesia. </p><p></p><p class="bulletIndent2">Nonoperative treatment consists of antibiotics (for all patients) and gallbladder drainage (for all septic or critically ill patients and noncritical patients who fail to respond after one to three days of antibiotic therapy). Drainage options include percutaneous cholecystostomy and endoscopic transpapillary or transmural drainage. (See <a class="local">'Poor surgical candidates'</a> above.)</p><p></p><p class="bulletIndent2">Once cholecystitis resolves with nonoperative treatment, we suggest reassessing the patient's risk for surgery and offering reasonable surgical candidates cholecystectomy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Without definitive treatment for gallstones, the risk for recurrent symptoms is high. </p><p></p><p class="bulletIndent2">Patients who continue to be high risk for surgery can be considered for percutaneous gallstone extraction with or without mechanical lithotripsy or simply observed and undergo interval cholecystectomy only for recurrent acute cholecystitis. (See <a class="local">'Subsequent care following drainage'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surgical approaches</strong> – For surgical treatment of patients with ACC, we recommend laparoscopic cholecystectomy over open cholecystectomy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_1" rel="external">Grade 1A</a>). Laparoscopic cholecystectomy should be attempted unless there is an absolute anesthetic contraindication to laparoscopic surgery or a lack of requisite surgical expertise. (See <a class="local">'Surgical approach'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Associated common bile duct stones</strong> – All patients should undergo standard preoperative laboratory and imaging tests and/or intraoperative cholangiography to look for concomitant common bile duct stones; those who are diagnosed with common bile duct stones should be treated accordingly with endoscopic removal or surgical common duct exploration. (See <a class="local">'Associated common bile duct stone'</a> above and  <a class="medical medical_review" href="/d/html/15093.html" rel="external">"Surgical common bile duct exploration"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Outcomes</strong> – Mortality associated with a single episode of acute cholecystitis depends upon the patient's health and surgical risk. Overall mortality is approximately 3 percent but is less than 1 percent in young, otherwise healthy patients and approaches 10 percent in high-risk patients or those with complications. (See <a class="local">'Morbidity and mortality'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Okamoto K, Suzuki K, Takada T, et al. Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis. J Hepatobiliary Pancreat Sci 2018; 25:55.</a></li><li><a class="nounderline abstract_t">Elta GH, Barnett JL. Meperidine need not be proscribed during sphincter of Oddi manometry. Gastrointest Endosc 1994; 40:7.</a></li><li><a class="nounderline abstract_t">Thompson DR. Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis. Am J Gastroenterol 2001; 96:1266.</a></li><li><a class="nounderline abstract_t">Thune A, Baker RA, Saccone GT, et al. Differing effects of pethidine and morphine on human sphincter of Oddi motility. Br J Surg 1990; 77:992.</a></li><li><a class="nounderline abstract_t">Fuks D, Cossé C, Régimbeau JM. Antibiotic therapy in acute calculous cholecystitis. J Visc Surg 2013; 150:3.</a></li><li><a class="nounderline abstract_t">Strasberg SM. Clinical practice. Acute calculous cholecystitis. N Engl J Med 2008; 358:2804.</a></li><li><a class="nounderline abstract_t">Järvinen H, Renkonen OV, Palmu A. Antibiotics in acute cholecystitis. Ann Clin Res 1978; 10:247.</a></li><li><a class="nounderline abstract_t">Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50:133.</a></li><li><a class="nounderline abstract_t">Kanafani ZA, Khalifé N, Kanj SS, et al. Antibiotic use in acute cholecystitis: practice patterns in the absence of evidence-based guidelines. J Infect 2005; 51:128.</a></li><li><a class="nounderline abstract_t">Mazeh H, Mizrahi I, Dior U, et al. Role of antibiotic therapy in mild acute calculus cholecystitis: a prospective randomized controlled trial. World J Surg 2012; 36:1750.</a></li><li><a class="nounderline abstract_t">van Braak WG, Ponten JEH, Loozen CS, et al. Antibiotic prophylaxis for acute cholecystectomy: PEANUTS II multicentre randomized non-inferiority clinical trial. Br J Surg 2022; 109:267.</a></li><li><a class="nounderline abstract_t">Landau O, Kott I, Deutsch AA, et al. Multifactorial analysis of septic bile and septic complications in biliary surgery. World J Surg 1992; 16:962.</a></li><li><a class="nounderline abstract_t">Csendes A, Burdiles P, Maluenda F, et al. Simultaneous bacteriologic assessment of bile from gallbladder and common bile duct in control subjects and patients with gallstones and common duct stones. Arch Surg 1996; 131:389.</a></li><li><a class="nounderline abstract_t">Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2018; 25:3.</a></li><li><a class="nounderline abstract_t">Regimbeau JM, Fuks D, Pautrat K, et al. Effect of postoperative antibiotic administration on postoperative infection following cholecystectomy for acute calculous cholecystitis: a randomized clinical trial. JAMA 2014; 312:145.</a></li><li><a class="nounderline abstract_t">de Santibañes M, Glinka J, Pelegrini P, et al. Extended antibiotic therapy versus placebo after laparoscopic cholecystectomy for mild and moderate acute calculous cholecystitis: A randomized double-blind clinical trial. Surgery 2018.</a></li><li><a class="nounderline abstract_t">Teefey SA, Dahiya N, Middleton WD, et al. Acute cholecystitis: do sonographic findings and WBC count predict gangrenous changes? AJR Am J Roentgenol 2013; 200:363.</a></li><li><a class="nounderline abstract_t">Bourikian S, Anand RJ, Aboutanos M, et al. Risk factors for acute gangrenous cholecystitis in emergency general surgery patients. Am J Surg 2015; 210:730.</a></li><li><a class="nounderline abstract_t">Nikfarjam M, Niumsawatt V, Sethu A, et al. Outcomes of contemporary management of gangrenous and non-gangrenous acute cholecystitis. HPB (Oxford) 2011; 13:551.</a></li><li><a class="nounderline abstract_t">Mok KW, Reddy R, Wood F, et al. Is C-reactive protein a useful adjunct in selecting patients for emergency cholecystectomy by predicting severe/gangrenous cholecystitis? Int J Surg 2014; 12:649.</a></li><li><a class="nounderline abstract_t">Wu B, Buddensick TJ, Ferdosi H, et al. Predicting gangrenous cholecystitis. HPB (Oxford) 2014; 16:801.</a></li><li><a class="nounderline abstract_t">Yokoe M, Hata J, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci 2018; 25:41.</a></li><li><a class="nounderline abstract_t">Hernandez M, Murphy B, Aho JM, et al. Validation of the AAST EGS acute cholecystitis grade and comparison with the Tokyo guidelines. Surgery 2018; 163:739.</a></li><li><a class="nounderline abstract_t">Tufo A, Pisano M, Ansaloni L, et al. Risk Prediction in Acute Calculous Cholecystitis: A Systematic Review and Meta-Analysis of Prognostic Factors and Predictive Models. J Laparoendosc Adv Surg Tech A 2021; 31:41.</a></li><li><a class="nounderline abstract_t">Yamashita Y, Takada T, Strasberg SM, et al. TG13 surgical management of acute cholecystitis. J Hepatobiliary Pancreat Sci 2013; 20:89.</a></li><li><a class="nounderline abstract_t">Pisano M, Allievi N, Gurusamy K, et al. 2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatment of acute calculus cholecystitis. World J Emerg Surg 2020; 15:61.</a></li><li><a class="nounderline abstract_t">Gallaher JR, Charles A. Acute Cholecystitis: A Review. JAMA 2022; 327:965.</a></li><li><a class="nounderline abstract_t">Puggioni A, Wong LL. A metaanalysis of laparoscopic cholecystectomy in patients with cirrhosis. J Am Coll Surg 2003; 197:921.</a></li><li><a class="nounderline abstract_t">Strömberg J, Hammarqvist F, Sadr-Azodi O, Sandblom G. Cholecystectomy in Patients with Liver Cirrhosis. Gastroenterol Res Pract 2015; 2015:783823.</a></li><li><a class="nounderline abstract_t">Lucidi V, Buggenhout A, Donckier V. Cholecystectomy in cirrhotic patients: pitfalls and reasonable recommendations. Acta Chir Belg 2009; 109:477.</a></li><li><a class="nounderline abstract_t">McGillicuddy EA, Schuster KM, Barre K, et al. Non-operative management of acute cholecystitis in the elderly. Br J Surg 2012; 99:1254.</a></li><li><a class="nounderline abstract_t">Fukami Y, Kurumiya Y, Mizuno K, et al. Cholecystectomy in octogenarians: be careful. Updates Surg 2014; 66:265.</a></li><li><a class="nounderline abstract_t">Hazzan D, Geron N, Golijanin D, et al. Laparoscopic cholecystectomy in octogenarians. Surg Endosc 2003; 17:773.</a></li><li><a class="nounderline abstract_t">Marcari RS, Lupinacci RM, Nadal LR, et al. Outcomes of laparoscopic cholecystectomy in octogenarians. JSLS 2012; 16:271.</a></li><li><a class="nounderline abstract_t">Kim SM, Shin MH, Choi NK. Safe and feasible outcomes of cholecystectomy in extremely elderly patients (octogenarians vs. nonagenarians). J Minim Invasive Surg 2021; 24:139.</a></li><li><a class="nounderline abstract_t">Pisano M, Ceresoli M, Cimbanassi S, et al. 2017 WSES and SICG guidelines on acute calcolous cholecystitis in elderly population. World J Emerg Surg 2019; 14:10.</a></li><li><a class="nounderline abstract_t">Wiggins T, Markar SR, Mackenzie H, et al. Evolution in the management of acute cholecystitis in the elderly: population-based cohort study. Surg Endosc 2018; 32:4078.</a></li><li><a class="nounderline abstract_t">Riall TS, Zhang D, Townsend CM Jr, et al. Failure to perform cholecystectomy for acute cholecystitis in elderly patients is associated with increased morbidity, mortality, and cost. J Am Coll Surg 2010; 210:668.</a></li><li><a class="nounderline abstract_t">Loozen CS, van Ramshorst B, van Santvoort HC, Boerma D. Early Cholecystectomy for Acute Cholecystitis in the Elderly Population: A Systematic Review and Meta-Analysis. Dig Surg 2017; 34:371.</a></li><li><a class="nounderline abstract_t">Nikfarjam M, Yeo D, Perini M, et al. Outcomes of cholecystectomy for treatment of acute cholecystitis in octogenarians. ANZ J Surg 2014; 84:943.</a></li><li><a class="nounderline abstract_t">Loozen CS, van Santvoort HC, van Duijvendijk P, et al. Laparoscopic cholecystectomy versus percutaneous catheter drainage for acute cholecystitis in high risk patients (CHOCOLATE): multicentre randomised clinical trial. BMJ 2018; 363:k3965.</a></li><li><a class="nounderline abstract_t">Vetrhus M, Søreide O, Nesvik I, Søndenaa K. Acute cholecystitis: delayed surgery or observation. A randomized clinical trial. Scand J Gastroenterol 2003; 38:985.</a></li><li><a class="nounderline abstract_t">Schmidt M, Søndenaa K, Vetrhus M, et al. Long-term follow-up of a randomized controlled trial of observation versus surgery for acute cholecystitis: non-operative management is an option in some patients. Scand J Gastroenterol 2011; 46:1257.</a></li><li><a class="nounderline abstract_t">Huang H, Zhang H, Yang D, et al. Percutaneous cholecystostomy versus emergency cholecystectomy for the treatment of acute calculous cholecystitis in high-risk surgical patients: a meta-analysis and systematic review. Updates Surg 2022; 74:55.</a></li><li><a class="nounderline abstract_t">Joseph B, Jehan F, Dacey M, et al. Evaluating the Relevance of the 2013 Tokyo Guidelines for the Diagnosis and Management of Cholecystitis. J Am Coll Surg 2018; 227:38.</a></li><li><a class="nounderline abstract_t">Hussain A, Lafaurie G, Hafeez R, El-Hasani S. Is Specialisation Needed in Laparoscopic Cholecystectomy? A Retrospective Cohort Study of 5122 Patients. Chirurgia (Bucur) 2020; 115:756.</a></li><li><a class="nounderline abstract_t">Andrews S. Does concentration of surgical expertise improve outcomes for laparoscopic cholecystectomy? 9 year audit cycle. Surgeon 2013; 11:309.</a></li><li><a class="nounderline abstract_t">Ansaloni L, Pisano M, Coccolini F, et al. 2016 WSES guidelines on acute calculous cholecystitis. World J Emerg Surg 2016; 11:25.</a></li><li><a class="nounderline abstract_t">Norrby S, Herlin P, Holmin T, et al. Early or delayed cholecystectomy in acute cholecystitis? A clinical trial. Br J Surg 1983; 70:163.</a></li><li><a class="nounderline abstract_t">Lahtinen J, Alhava EM, Aukee S. Acute cholecystitis treated by early and delayed surgery. A controlled clinical trial. Scand J Gastroenterol 1978; 13:673.</a></li><li><a class="nounderline abstract_t">McArthur P, Cuschieri A, Sells RA, Shields R. Controlled clinical trial comparing early with interval cholecystectomy for acute cholecystitis. Br J Surg 1975; 62:850.</a></li><li><a class="nounderline abstract_t">Brooks KR, Scarborough JE, Vaslef SN, Shapiro ML. No need to wait: an analysis of the timing of cholecystectomy during admission for acute cholecystitis using the American College of Surgeons National Surgical Quality Improvement Program database. J Trauma Acute Care Surg 2013; 74:167.</a></li><li><a class="nounderline abstract_t">Gutt CN, Encke J, Köninger J, et al. Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304). Ann Surg 2013; 258:385.</a></li><li><a class="nounderline abstract_t">Banz V, Gsponer T, Candinas D, Güller U. Population-based analysis of 4113 patients with acute cholecystitis: defining the optimal time-point for laparoscopic cholecystectomy. Ann Surg 2011; 254:964.</a></li><li><a class="nounderline abstract_t">de Mestral C, Rotstein OD, Laupacis A, et al. Comparative operative outcomes of early and delayed cholecystectomy for acute cholecystitis: a population-based propensity score analysis. Ann Surg 2014; 259:10.</a></li><li><a class="nounderline abstract_t">Papi C, Catarci M, D'Ambrosio L, et al. Timing of cholecystectomy for acute calculous cholecystitis: a meta-analysis. Am J Gastroenterol 2004; 99:147.</a></li><li><a class="nounderline abstract_t">Gurusamy KS, Davidson C, Gluud C, Davidson BR. Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis. Cochrane Database Syst Rev 2013; :CD005440.</a></li><li><a class="nounderline abstract_t">Macafee DA, Humes DJ, Bouliotis G, et al. Prospective randomized trial using cost-utility analysis of early versus delayed laparoscopic cholecystectomy for acute gallbladder disease. Br J Surg 2009; 96:1031.</a></li><li><a class="nounderline abstract_t">Dua A, Dua A, Desai SS, et al. Gender based differences in management and outcomes of cholecystitis. Am J Surg 2013; 206:641.</a></li><li><a class="nounderline abstract_t">Yadav RP, Adhikary S, Agrawal CS, et al. A comparative study of early vs. delayed laparoscopic cholecystectomy in acute cholecystitis. Kathmandu Univ Med J (KUMJ) 2009; 7:16.</a></li><li><a class="nounderline abstract_t">Song GM, Bian W, Zeng XT, et al. Laparoscopic cholecystectomy for acute cholecystitis: early or delayed?: Evidence from a systematic review of discordant meta-analyses. Medicine (Baltimore) 2016; 95:e3835.</a></li><li><a class="nounderline abstract_t">Wu XD, Tian X, Liu MM, et al. Meta-analysis comparing early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg 2015; 102:1302.</a></li><li><a class="nounderline abstract_t">Borzellino G, Khuri S, Pisano M, et al. Timing of early laparoscopic cholecystectomy for acute calculous cholecystitis: a meta-analysis of randomized clinical trials. World J Emerg Surg 2021; 16:16.</a></li><li><a class="nounderline abstract_t">Blohm M, Österberg J, Sandblom G, et al. The Sooner, the Better? The Importance of Optimal Timing of Cholecystectomy in Acute Cholecystitis: Data from the National Swedish Registry for Gallstone Surgery, GallRiks. J Gastrointest Surg 2017; 21:33.</a></li><li><a class="nounderline abstract_t">Altieri MS, Brunt LM, Yang J, et al. Early cholecystectomy (&lt; 72 h) is associated with lower rate of complications and bile duct injury: a study of 109,862 cholecystectomies in the state of New York. Surg Endosc 2020; 34:3051.</a></li><li><a class="nounderline abstract_t">Farooq T, Buchanan G, Manda V, et al. Is early laparoscopic cholecystectomy safe after the "safe period"? J Laparoendosc Adv Surg Tech A 2009; 19:471.</a></li><li><a class="nounderline abstract_t">Litwin DE, Cahan MA. Laparoscopic cholecystectomy. Surg Clin North Am 2008; 88:1295.</a></li><li><a class="nounderline abstract_t">Pessaux P, Tuech JJ, Regenet N, et al. [Laparoscopic cholecystectomy in the treatment of acute cholecystitis. Prospective non-randomized study]. Gastroenterol Clin Biol 2000; 24:400.</a></li><li><a class="nounderline abstract_t">Roulin D, Saadi A, Di Mare L, et al. Early Versus Delayed Cholecystectomy for Acute Cholecystitis, Are the 72 hours Still the Rule?: A Randomized Trial. Ann Surg 2016; 264:717.</a></li><li><a class="nounderline abstract_t">Gomes RM, Mehta NT, Varik V, Doctor NH. No 72-hour pathological boundary for safe early laparoscopic cholecystectomy in acute cholecystitis: a clinicopathological study. Ann Gastroenterol 2013; 26:340.</a></li><li><a class="nounderline abstract_t">Coccolini F, Catena F, Pisano M, et al. Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis. Int J Surg 2015; 18:196.</a></li><li><a class="nounderline abstract_t">Vollmer CM Jr, Callery MP. Biliary injury following laparoscopic cholecystectomy: why still a problem? Gastroenterology 2007; 133:1039.</a></li><li><a class="nounderline abstract_t">Khan MH, Howard TJ, Fogel EL, et al. Frequency of biliary complications after laparoscopic cholecystectomy detected by ERCP: experience at a large tertiary referral center. Gastrointest Endosc 2007; 65:247.</a></li><li><a class="nounderline abstract_t">Wakabayashi G, Iwashita Y, Hibi T, et al. Tokyo Guidelines 2018: surgical management of acute cholecystitis: safe steps in laparoscopic cholecystectomy for acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci 2018; 25:73.</a></li><li><a class="nounderline abstract_t">Baron TH, Grimm IS, Swanstrom LL. Interventional Approaches to Gallbladder Disease. N Engl J Med 2015; 373:357.</a></li><li><a class="nounderline abstract_t">Morse BC, Smith JB, Lawdahl RB, Roettger RH. Management of acute cholecystitis in critically ill patients: contemporary role for cholecystostomy and subsequent cholecystectomy. Am Surg 2010; 76:708.</a></li><li><a class="nounderline abstract_t">Winbladh A, Gullstrand P, Svanvik J, Sandström P. Systematic review of cholecystostomy as a treatment option in acute cholecystitis. HPB (Oxford) 2009; 11:183.</a></li><li><a class="nounderline abstract_t">Melin MM, Sarr MG, Bender CE, van Heerden JA. Percutaneous cholecystostomy: a valuable technique in high-risk patients with presumed acute cholecystitis. Br J Surg 1995; 82:1274.</a></li><li><a class="nounderline abstract_t">Ito K, Fujita N, Noda Y, et al. Percutaneous cholecystostomy versus gallbladder aspiration for acute cholecystitis: a prospective randomized controlled trial. AJR Am J Roentgenol 2004; 183:193.</a></li><li><a class="nounderline abstract_t">Davis CA, Landercasper J, Gundersen LH, Lambert PJ. Effective use of percutaneous cholecystostomy in high-risk surgical patients: techniques, tube management, and results. Arch Surg 1999; 134:727.</a></li><li><a class="nounderline abstract_t">Byrne MF, Suhocki P, Mitchell RM, et al. Percutaneous cholecystostomy in patients with acute cholecystitis: experience of 45 patients at a US referral center. J Am Coll Surg 2003; 197:206.</a></li><li><a class="nounderline abstract_t">Hatzidakis AA, Prassopoulos P, Petinarakis I, et al. Acute cholecystitis in high-risk patients: percutaneous cholecystostomy vs conservative treatment. Eur Radiol 2002; 12:1778.</a></li><li><a class="nounderline abstract_t">Siddiqui A, Kunda R, Tyberg A, et al. Three-way comparative study of endoscopic ultrasound-guided transmural gallbladder drainage using lumen-apposing metal stents versus endoscopic transpapillary drainage versus percutaneous cholecystostomy for gallbladder drainage in high-risk surgical patients with acute cholecystitis: clinical outcomes and success in an International, Multicenter Study. Surg Endosc 2019; 33:1260.</a></li><li><a class="nounderline abstract_t">Luk SW, Irani S, Krishnamoorthi R, et al. Endoscopic ultrasound-guided gallbladder drainage versus percutaneous cholecystostomy for high risk surgical patients with acute cholecystitis: a systematic review and meta-analysis. Endoscopy 2019; 51:722.</a></li><li><a class="nounderline abstract_t">Mohan BP, Khan SR, Trakroo S, et al. Endoscopic ultrasound-guided gallbladder drainage, transpapillary drainage, or percutaneous drainage in high risk acute cholecystitis patients: a systematic review and comparative meta-analysis. Endoscopy 2020; 52:96.</a></li><li><a class="nounderline abstract_t">Chou CK, Lee KC, Chan CC, et al. Early Percutaneous Cholecystostomy in Severe Acute Cholecystitis Reduces the Complication Rate and Duration of Hospital Stay. Medicine (Baltimore) 2015; 94:e1096.</a></li><li><a class="nounderline abstract_t">Barak O, Elazary R, Appelbaum L, et al. Conservative treatment for acute cholecystitis: clinical and radiographic predictors of failure. Isr Med Assoc J 2009; 11:739.</a></li><li><a class="nounderline abstract_t">Joseph T, Unver K, Hwang GL, et al. Percutaneous cholecystostomy for acute cholecystitis: ten-year experience. J Vasc Interv Radiol 2012; 23:83.</a></li><li><a class="nounderline abstract_t">Dewhurst C, Kane RA, Mhuircheartaigh JN, et al. Complication rate of ultrasound-guided percutaneous cholecystostomy in patients with coagulopathy. AJR Am J Roentgenol 2012; 199:W753.</a></li><li><a class="nounderline abstract_t">Gurusamy KS, Rossi M, Davidson BR. Percutaneous cholecystostomy for high-risk surgical patients with acute calculous cholecystitis. Cochrane Database Syst Rev 2013; :CD007088.</a></li><li><a class="nounderline abstract_t">Akyürek N, Salman B, Yüksel O, et al. Management of acute calculous cholecystitis in high-risk patients: percutaneous cholecystotomy followed by early laparoscopic cholecystectomy. Surg Laparosc Endosc Percutan Tech 2005; 15:315.</a></li><li><a class="nounderline abstract_t">Karakayali FY, Akdur A, Kirnap M, et al. Emergency cholecystectomy vs percutaneous cholecystostomy plus delayed cholecystectomy for patients with acute cholecystitis. Hepatobiliary Pancreat Dis Int 2014; 13:316.</a></li><li><a class="nounderline abstract_t">Abi-Haidar Y, Sanchez V, Williams SA, Itani KM. Revisiting percutaneous cholecystostomy for acute cholecystitis based on a 10-year experience. Arch Surg 2012; 147:416.</a></li><li><a class="nounderline abstract_t">Smith TJ, Manske JG, Mathiason MA, et al. Changing trends and outcomes in the use of percutaneous cholecystostomy tubes for acute cholecystitis. Ann Surg 2013; 257:1112.</a></li><li><a class="nounderline abstract_t">Schlottmann F, Gaber C, Strassle PD, et al. Cholecystectomy Vs. Cholecystostomy for the Management of Acute Cholecystitis in Elderly Patients. J Gastrointest Surg 2019; 23:503.</a></li><li><a class="nounderline abstract_t">Sanaiha Y, Juo YY, Rudasill SE, et al. Percutaneous cholecystostomy for grade III acute cholecystitis is associated with worse outcomes. Am J Surg 2020; 220:197.</a></li><li><a class="nounderline abstract_t">Duszak R Jr, Behrman SW. National trends in percutaneous cholecystostomy between 1994 and 2009: perspectives from Medicare provider claims. J Am Coll Radiol 2012; 9:474.</a></li><li><a class="nounderline abstract_t">Parikh SS, Lindquester WS, Dhangana R. National Cholecystostomy Tube Placement and Cholecystectomy Trends From 2010 to 2018. J Am Coll Radiol 2023; 20:537.</a></li><li><a class="nounderline abstract_t">Itoi T, Sofuni A, Itokawa F, et al. Endoscopic transpapillary gallbladder drainage in patients with acute cholecystitis in whom percutaneous transhepatic approach is contraindicated or anatomically impossible (with video). Gastrointest Endosc 2008; 68:455.</a></li><li><a class="nounderline abstract_t">Kjaer DW, Kruse A, Funch-Jensen P. Endoscopic gallbladder drainage of patients with acute cholecystitis. Endoscopy 2007; 39:304.</a></li><li><a class="nounderline abstract_t">Itoi T, Kawakami H, Katanuma A, et al. Endoscopic nasogallbladder tube or stent placement in acute cholecystitis: a preliminary prospective randomized trial in Japan (with videos). Gastrointest Endosc 2015; 81:111.</a></li><li><a class="nounderline abstract_t">Mori Y, Itoi T, Baron TH, et al. Tokyo Guidelines 2018: management strategies for gallbladder drainage in patients with acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci 2018; 25:87.</a></li><li><a class="nounderline abstract_t">Lee TH, Park DH, Lee SS, et al. Outcomes of endoscopic transpapillary gallbladder stenting for symptomatic gallbladder diseases: a multicenter prospective follow-up study. Endoscopy 2011; 43:702.</a></li><li><a class="nounderline abstract_t">McCarthy ST, Tujios S, Fontana RJ, et al. Endoscopic Transpapillary Gallbladder Stent Placement Is Safe and Effective in High-Risk Patients Without Cirrhosis. Dig Dis Sci 2015; 60:2516.</a></li><li><a class="nounderline abstract_t">Tujios SR, Rahnama-Moghadam S, Elmunzer JB, et al. Transpapillary Gallbladder Stents Can Stabilize or Improve Decompensated Cirrhosis in Patients Awaiting Liver Transplantation. J Clin Gastroenterol 2015; 49:771.</a></li><li><a class="nounderline abstract_t">Anderloni A, Buda A, Vieceli F, et al. Endoscopic ultrasound-guided transmural stenting for gallbladder drainage in high-risk patients with acute cholecystitis: a systematic review and pooled analysis. Surg Endosc 2016; 30:5200.</a></li><li><a class="nounderline abstract_t">Peñas-Herrero I, de la Serna-Higuera C, Perez-Miranda M. Endoscopic ultrasound-guided gallbladder drainage for the management of acute cholecystitis (with video). J Hepatobiliary Pancreat Sci 2015; 22:35.</a></li><li><a class="nounderline abstract_t">Dollhopf M, Larghi A, Will U, et al. EUS-guided gallbladder drainage in patients with acute cholecystitis and high surgical risk using an electrocautery-enhanced lumen-apposing metal stent device. Gastrointest Endosc 2017; 86:636.</a></li><li><a class="nounderline abstract_t">Teoh AYB, Kitano M, Itoi T, et al. Endosonography-guided gallbladder drainage versus percutaneous cholecystostomy in very high-risk surgical patients with acute cholecystitis: an international randomised multicentre controlled superiority trial (DRAC 1). Gut 2020; 69:1085.</a></li><li><a class="nounderline abstract_t">McKay A, Abulfaraj M, Lipschitz J. Short- and long-term outcomes following percutaneous cholecystostomy for acute cholecystitis in high-risk patients. Surg Endosc 2012; 26:1343.</a></li><li><a class="nounderline abstract_t">Horn T, Christensen SD, Kirkegård J, et al. Percutaneous cholecystostomy is an effective treatment option for acute calculous cholecystitis: a 10-year experience. HPB (Oxford) 2015; 17:326.</a></li><li><a class="nounderline abstract_t">Jang WS, Lim JU, Joo KR, et al. Outcome of conservative percutaneous cholecystostomy in high-risk patients with acute cholecystitis and risk factors leading to surgery. Surg Endosc 2015; 29:2359.</a></li><li><a class="nounderline abstract_t">de Mestral C, Rotstein OD, Laupacis A, et al. A population-based analysis of the clinical course of 10,304 patients with acute cholecystitis, discharged without cholecystectomy. J Trauma Acute Care Surg 2013; 74:26.</a></li><li><a class="nounderline abstract_t">Stanek A, Dohan A, Barkun J, et al. Percutaneous cholecystostomy: A simple bridge to surgery or an alternative option for the management of acute cholecystitis? Am J Surg 2018; 216:595.</a></li><li><a class="nounderline abstract_t">Cherng N, Witkowski ET, Sneider EB, et al. Use of cholecystostomy tubes in the management of patients with primary diagnosis of acute cholecystitis. J Am Coll Surg 2012; 214:196.</a></li><li><a class="nounderline abstract_t">de Mestral C, Gomez D, Haas B, et al. Cholecystostomy: a bridge to hospital discharge but not delayed cholecystectomy. J Trauma Acute Care Surg 2013; 74:175.</a></li><li><a class="nounderline abstract_t">Stirrat J, Patel NR, Stella SF, et al. Safety and Efficacy of Percutaneous Gallstone Extraction in High-Risk Patients: An Alternative to Cholecystectomy or Long-Term Drainage? J Am Coll Surg 2021; 232:195.</a></li><li><a class="nounderline abstract_t">Macchini D, Degrate L, Oldani M, et al. Timing of percutaneous cholecystostomy tube removal: systematic review. Minerva Chir 2016; 71:415.</a></li><li><a class="nounderline abstract_t">Nielsen LB, Harboe KM, Bardram L. Cholecystectomy for the elderly: no hesitation for otherwise healthy patients. Surg Endosc 2014; 28:171.</a></li><li><a class="nounderline abstract_t">Kamarajah SK, Karri S, Bundred JR, et al. Perioperative outcomes after laparoscopic cholecystectomy in elderly patients: a systematic review and meta-analysis. Surg Endosc 2020; 34:4727.</a></li><li><a class="nounderline abstract_t">Karamanos E, Sivrikoz E, Beale E, et al. Effect of diabetes on outcomes in patients undergoing emergent cholecystectomy for acute cholecystitis. World J Surg 2013; 37:2257.</a></li></ol></div><div id="topicVersionRevision">Topic 3684 Version 53.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29045062" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8163140" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Meperidine need not be proscribed during sphincter of Oddi manometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11316181" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2207591" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Differing effects of pethidine and morphine on human sphincter of Oddi motility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23433832" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Antibiotic therapy in acute calculous cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18579815" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Clinical practice. Acute calculous cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/736504" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Antibiotics in acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20034345" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16038763" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Antibiotic use in acute cholecystitis: practice patterns in the absence of evidence-based guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22456803" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Role of antibiotic therapy in mild acute calculus cholecystitis: a prospective randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35020797" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Antibiotic prophylaxis for acute cholecystectomy: PEANUTS II multicentre randomized non-inferiority clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1462638" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Multifactorial analysis of septic bile and septic complications in biliary surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8615724" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Simultaneous bacteriologic assessment of bile from gallbladder and common bile duct in control subjects and patients with gallstones and common duct stones.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29090866" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25005651" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Effect of postoperative antibiotic administration on postoperative infection following cholecystectomy for acute calculous cholecystitis: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29506881" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Extended antibiotic therapy versus placebo after laparoscopic cholecystectomy for mild and moderate acute calculous cholecystitis: A randomized double-blind clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23345358" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Acute cholecystitis: do sonographic findings and WBC count predict gangrenous changes?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26186803" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Risk factors for acute gangrenous cholecystitis in emergency general surgery patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21762298" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Outcomes of contemporary management of gangrenous and non-gangrenous acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24856179" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Is C-reactive protein a useful adjunct in selecting patients for emergency cholecystectomy by predicting severe/gangrenous cholecystitis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24635779" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Predicting gangrenous cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29032636" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29325783" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Validation of the AAST EGS acute cholecystitis grade and comparison with the Tokyo guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32716737" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Risk Prediction in Acute Calculous Cholecystitis: A Systematic Review and Meta-Analysis of Prognostic Factors and Predictive Models.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23307007" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : TG13 surgical management of acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33153472" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : 2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatment of acute calculus cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35258527" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Acute Cholecystitis: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14644279" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A metaanalysis of laparoscopic cholecystectomy in patients with cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26788053" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Cholecystectomy in Patients with Liver Cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19803258" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Cholecystectomy in cirrhotic patients: pitfalls and reasonable recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22829411" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Non-operative management of acute cholecystitis in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25266894" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Cholecystectomy in octogenarians: be careful.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12616388" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Laparoscopic cholecystectomy in octogenarians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23477177" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Outcomes of laparoscopic cholecystectomy in octogenarians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35600104" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Safe and feasible outcomes of cholecystectomy in extremely elderly patients (octogenarians vs. nonagenarians).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30867674" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : 2017 WSES and SICG guidelines on acute calcolous cholecystitis in elderly population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30046948" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Evolution in the management of acute cholecystitis in the elderly: population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20421027" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Failure to perform cholecystectomy for acute cholecystitis in elderly patients is associated with increased morbidity, mortality, and cost.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28095385" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Early Cholecystectomy for Acute Cholecystitis in the Elderly Population: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23910372" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Outcomes of cholecystectomy for treatment of acute cholecystitis in octogenarians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30297544" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Laparoscopic cholecystectomy versus percutaneous catheter drainage for acute cholecystitis in high risk patients (CHOCOLATE): multicentre randomised clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14531537" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Acute cholecystitis: delayed surgery or observation. A randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21736531" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Long-term follow-up of a randomized controlled trial of observation versus surgery for acute cholecystitis: non-operative management is an option in some patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33991327" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Percutaneous cholecystostomy versus emergency cholecystectomy for the treatment of acute calculous cholecystitis in high-risk surgical patients: a meta-analysis and systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29580879" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Evaluating the Relevance of the 2013 Tokyo Guidelines for the Diagnosis and Management of Cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33378634" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Is Specialisation Needed in Laparoscopic Cholecystectomy? A Retrospective Cohort Study of 5122 Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23916664" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Does concentration of surgical expertise improve outcomes for laparoscopic cholecystectomy? 9 year audit cycle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27307785" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : 2016 WSES guidelines on acute calculous cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6338991" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Early or delayed cholecystectomy in acute cholecystitis? A clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/358366" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Acute cholecystitis treated by early and delayed surgery. A controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1104043" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Controlled clinical trial comparing early with interval cholecystectomy for acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23271092" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : No need to wait: an analysis of the timing of cholecystectomy during admission for acute cholecystitis using the American College of Surgeons National Surgical Quality Improvement Program database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24022431" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21817893" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Population-based analysis of 4113 patients with acute cholecystitis: defining the optimal time-point for laparoscopic cholecystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23979286" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Comparative operative outcomes of early and delayed cholecystectomy for acute cholecystitis: a population-based propensity score analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14687156" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Timing of cholecystectomy for acute calculous cholecystitis: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23813477" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19672930" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Prospective randomized trial using cost-utility analysis of early versus delayed laparoscopic cholecystectomy for acute gallbladder disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24011570" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Gender based differences in management and outcomes of cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19483447" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : A comparative study of early vs. delayed laparoscopic cholecystectomy in acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27281088" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Laparoscopic cholecystectomy for acute cholecystitis: early or delayed?: Evidence from a systematic review of discordant meta-analyses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26265548" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Meta-analysis comparing early versus delayed laparoscopic cholecystectomy for acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33766077" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Timing of early laparoscopic cholecystectomy for acute calculous cholecystitis: a meta-analysis of randomized clinical trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27649704" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The Sooner, the Better? The Importance of Optimal Timing of Cholecystectomy in Acute Cholecystitis: Data from the National Swedish Registry for Gallstone Surgery, GallRiks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31376010" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Early cholecystectomy (&lt; 72 h) is associated with lower rate of complications and bile duct injury: a study of 109,862 cholecystectomies in the state of New York.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19489677" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Is early laparoscopic cholecystectomy safe after the "safe period"?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18992596" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Laparoscopic cholecystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10844284" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : [Laparoscopic cholecystectomy in the treatment of acute cholecystitis. Prospective non-randomized study].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27741006" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Early Versus Delayed Cholecystectomy for Acute Cholecystitis, Are the 72 hours Still the Rule?: A Randomized Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24714318" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : No 72-hour pathological boundary for safe early laparoscopic cholecystectomy in acute cholecystitis: a clinicopathological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25958296" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17854607" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Biliary injury following laparoscopic cholecystectomy: why still a problem?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17258983" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Frequency of biliary complications after laparoscopic cholecystectomy detected by ERCP: experience at a large tertiary referral center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29095575" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Tokyo Guidelines 2018: surgical management of acute cholecystitis: safe steps in laparoscopic cholecystectomy for acute cholecystitis (with videos).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26200981" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Interventional Approaches to Gallbladder Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20698375" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Management of acute cholecystitis in critically ill patients: contemporary role for cholecystostomy and subsequent cholecystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19590646" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Systematic review of cholecystostomy as a treatment option in acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7552017" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Percutaneous cholecystostomy: a valuable technique in high-risk patients with presumed acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15208137" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Percutaneous cholecystostomy versus gallbladder aspiration for acute cholecystitis: a prospective randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10401823" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Effective use of percutaneous cholecystostomy in high-risk surgical patients: techniques, tube management, and results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12892798" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Percutaneous cholecystostomy in patients with acute cholecystitis: experience of 45 patients at a US referral center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12111069" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Acute cholecystitis in high-risk patients: percutaneous cholecystostomy vs conservative treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30209610" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Three-way comparative study of endoscopic ultrasound-guided transmural gallbladder drainage using lumen-apposing metal stents versus endoscopic transpapillary drainage versus percutaneous cholecystostomy for gallbladder drainage in high-risk surgical patients with acute cholecystitis: clinical outcomes and success in an International, Multicenter Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31238375" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Endoscopic ultrasound-guided gallbladder drainage versus percutaneous cholecystostomy for high risk surgical patients with acute cholecystitis: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31645067" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Endoscopic ultrasound-guided gallbladder drainage, transpapillary drainage, or percutaneous drainage in high risk acute cholecystitis patients: a systematic review and comparative meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26166097" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Early Percutaneous Cholecystostomy in Severe Acute Cholecystitis Reduces the Complication Rate and Duration of Hospital Stay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20166341" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Conservative treatment for acute cholecystitis: clinical and radiographic predictors of failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22133709" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Percutaneous cholecystostomy for acute cholecystitis: ten-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23169749" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Complication rate of ultrasound-guided percutaneous cholecystostomy in patients with coagulopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23939652" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Percutaneous cholecystostomy for high-risk surgical patients with acute calculous cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16340560" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Management of acute calculous cholecystitis in high-risk patients: percutaneous cholecystotomy followed by early laparoscopic cholecystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24919616" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Emergency cholecystectomy vs percutaneous cholecystostomy plus delayed cholecystectomy for patients with acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22785633" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Revisiting percutaneous cholecystostomy for acute cholecystitis based on a 10-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23263191" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Changing trends and outcomes in the use of percutaneous cholecystostomy tubes for acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30225792" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Cholecystectomy Vs. Cholecystostomy for the Management of Acute Cholecystitis in Elderly Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31812256" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Percutaneous cholecystostomy for grade III acute cholecystitis is associated with worse outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22748787" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : National trends in percutaneous cholecystostomy between 1994 and 2009: perspectives from Medicare provider claims.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37127221" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : National Cholecystostomy Tube Placement and Cholecystectomy Trends From 2010 to 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18561927" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Endoscopic transpapillary gallbladder drainage in patients with acute cholecystitis in whom percutaneous transhepatic approach is contraindicated or anatomically impossible (with video).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17427067" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Endoscopic gallbladder drainage of patients with acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25527052" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Endoscopic nasogallbladder tube or stent placement in acute cholecystitis: a preliminary prospective randomized trial in Japan (with videos).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28888080" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Tokyo Guidelines 2018: management strategies for gallbladder drainage in patients with acute cholecystitis (with videos).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21425042" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Outcomes of endoscopic transpapillary gallbladder stenting for symptomatic gallbladder diseases: a multicenter prospective follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25287001" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Endoscopic Transpapillary Gallbladder Stent Placement Is Safe and Effective in High-Risk Patients Without Cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25437155" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Transpapillary Gallbladder Stents Can Stabilize or Improve Decompensated Cirrhosis in Patients Awaiting Liver Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27059975" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Endoscopic ultrasound-guided transmural stenting for gallbladder drainage in high-risk patients with acute cholecystitis: a systematic review and pooled analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25392972" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Endoscopic ultrasound-guided gallbladder drainage for the management of acute cholecystitis (with video).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28259594" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : EUS-guided gallbladder drainage in patients with acute cholecystitis and high surgical risk using an electrocautery-enhanced lumen-apposing metal stent device.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32165407" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Endosonography-guided gallbladder drainage versus percutaneous cholecystostomy in very high-risk surgical patients with acute cholecystitis: an international randomised multicentre controlled superiority trial (DRAC 1).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22089258" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Short- and long-term outcomes following percutaneous cholecystostomy for acute cholecystitis in high-risk patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25395238" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Percutaneous cholecystostomy is an effective treatment option for acute calculous cholecystitis: a 10-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25487543" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Outcome of conservative percutaneous cholecystostomy in high-risk patients with acute cholecystitis and risk factors leading to surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23271073" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : A population-based analysis of the clinical course of 10,304 patients with acute cholecystitis, discharged without cholecystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29429546" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Percutaneous cholecystostomy: A simple bridge to surgery or an alternative option for the management of acute cholecystitis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22192897" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Use of cholecystostomy tubes in the management of patients with primary diagnosis of acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23271093" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Cholecystostomy: a bridge to hospital discharge but not delayed cholecystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33010429" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Safety and Efficacy of Percutaneous Gallstone Extraction in High-Risk Patients: An Alternative to Cholecystectomy or Long-Term Drainage?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27280869" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Timing of percutaneous cholecystostomy tube removal: systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23996332" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Cholecystectomy for the elderly: no hesitation for otherwise healthy patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32661706" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Perioperative outcomes after laparoscopic cholecystectomy in elderly patients: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23677561" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Effect of diabetes on outcomes in patients undergoing emergent cholecystectomy for acute cholecystitis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
